Stay updated with breaking news from Transform Patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predicted forced vital capacity versus placeboTreatment effect was consistent with or without background therapy and BMS-986278 was well tolerated, with rates of adverse...
PRINCETON, N.J.--(BUSINESS WIRE)--Sep 9, 2023--
Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predicted forced vital capacity versus...
Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predicted forced vital capacity versus placebo Treatment effect was
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global Healthcare Cybersecurity Market by Offering (Solutions and Services), Solution Type, Threat Type,...